Trials / Completed
CompletedNCT00857753
Relative Bioavailability of a Fentanyl Patch
A Study to Evaluate the Relative Bioavailability of a Fentanyl PAtch Transdermal Delivery System (25 ug/hr) (Sandoz) Compared to Duragesic (Fentanyl Transdermal SYstem 25 ug/hr Patches (Alza)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl patch 25 ug/nr Sandoz | |
| DRUG | Duragesic |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2009-03-09
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00857753. Inclusion in this directory is not an endorsement.